CDNS vs PPCB · P/E 82, rev $5.30B vs P/E 0.0, $3.9M cap
Cadence Design Systems Inc (CDNS) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Cadence Design Systems Inc (CDNS) is a software - application company listed on US.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported CDNS revenue for 2025-12-31 was $5.30B. Net income was $1.11B. Revenue was up 14.1% from 2024-12-31 to 2025-12-31. CDNS currently screens at market cap $88.27B and trailing P/E 82.0.
PPCB does not have a complete income-statement cache yet.
CDNS currently screens at market cap $88.27B and trailing P/E 82.0. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the CDNS and PPCB stock pages for the full models.
Not investment advice.